Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and Europe

12 Oct 2016

Abstract excerpt

In vitro activity of tedizolid and comparators against 11,231 Gram-positive clinical isolates from the United States (84 centers) and Europe (115 centers) were summarized as part of the Surveillance of Tedizolid Activity and Resistance program between 2009 and 2013. Susceptibility testing was performed according to Clinical Laboratory and Standards Institute (CLSI) guidelines. Minimum inhibitory concentration...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antimicrobial Resistance in Staphylococcus
Share to Bacterial Identification and Susceptibility Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27866673
DOI: 10.1016/j.diagmicrobio.2016.10.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and EuropePMID 27866673Read ↗

Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.Semantic proximity Read ↗

In vitro activity of tedizolid against linezolid-resistant staphylococci and enterococci.Semantic proximity Read ↗

Effect of tedizolid on clinical Enterococcus isolates: in vitro activity, distribution of virulence factor, resistance genes and multilocus sequence typingSemantic proximity Read ↗

Tedizolid for the Management of Human Infections: In Vitro CharacteristicsSemantic proximity Read ↗

New Gram-Positive Agents: the Next Generation of Oxazolidinones and LipoglycopeptidesSemantic proximity Read ↗

In Vitro Activity of Tedizolid against Mycobacterium tuberculosisSemantic proximity Read ↗

Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.Semantic proximity Read ↗

Thrombocytopenia and Tedizolid: A new ally in hematologic patients? Brief literature review and a clinical caseSemantic proximity Read ↗

Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.Semantic proximity Read ↗

Antibacterial and anti-biofilm activity of radezolid against Staphylococcus aureus clinical isolates from ChinaSemantic proximity Read ↗

Zyvox(R) Annual Appraisal of Potency and Spectrum (ZAAPS) Program: report of linezolid activity over 9 years (2004-12)Semantic proximity Read ↗

Identification of a novel tedizolid resistance mutation in rpoB of MRSA after in vitro serial passage.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.